论文部分内容阅读
目的:探讨在治疗急性上呼吸道感染时采用的药物种类和用药方法。方法:从2013年1月至2015年10月来该院治疗上呼吸道感染的患者中选出32例,对患者的治疗方案进行回顾性分析,重点记录患者药物使用种类、频率、药物联用方式、用药途径。结果:本次研究中患者使用克林霉素的几率最大,占31.25%(10/32);其次是炎琥宁,占比25.00%(8/32);第三是赖氨匹林,占比15.63%(5/32)。联用方式当中单用比例最大,为87.50%(28/32);二联用法占比9.38%(3/32);三联占比3.12%(1/32);用药途径中单纯注射治疗占比最大,为78.13%(25/32);单纯口服治疗占比12.50%(4/32);静脉注射联合口服占比9.37%(3/32)。结论:治疗急性上呼吸道感染时需先了解患者的病情,并根据实际情况进行治疗,提高治疗的规范性。
Objective: To explore the types of drugs used in the treatment of acute upper respiratory tract infection. Methods: From January 2013 to October 2015, 32 cases of upper respiratory tract infection were selected from this hospital. The treatment regimen of the patients was retrospectively analyzed. The type of drug used, frequency, drug combination , Route of administration. Results: The incidence of clindamycin was the highest in this study, accounting for 31.25% (10/32), followed by metronidazole (25.00%, 8/32), and the third was lysipatrine Than 15.63% (5/32). The combined use of single-use ratio was the largest, 87.50% (28/32); use of the two accounted for 9.38% (3/32); triple accounted for 3.12% (1/32); The largest, 78.13% (25/32); simple oral treatment accounted for 12.50% (4/32); intravenous combination of oral accounted for 9.37% (3/32). Conclusion: In the treatment of acute upper respiratory tract infection, the patient’s condition needs to be known first and the treatment should be conducted according to the actual situation to improve the standardization of treatment.